Fu-gui Ye

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Sitravatinib plus tislelizumab in locally recurrent or metastatic triple-negative breast cancer: a multi-cohort, single-arm, phase II clinical trial (SPARK Trial).

Sitravatinib plus tislelizumab in locally recurrent or metastatic triple-negative breast cancer: a multi-cohort, single-arm, phase II clinical trial (SPARK Trial).

Journal: Molecular cancer
Published: April 28, 2025

Homologous recombination deficiency and glycolysis-related pathway in adjuvant chemotherapy for triple-negative breast cancer: A genomic landscape and biomarker assessment of the PATTERN trial.

Homologous recombination deficiency and glycolysis-related pathway in adjuvant chemotherapy for triple-negative breast cancer: A genomic landscape and biomarker assessment of the PATTERN trial.

Journal: Clinical and translational medicine
Published: June 06, 2021

Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial.

Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial.

Journal: JAMA oncology
Published: August 14, 2020

Clinicopathologic profiling and oncologic outcomes of secretory carcinoma of the breast.

Clinicopathologic profiling and oncologic outcomes of secretory carcinoma of the breast.

Journal: Scientific reports
Published: August 04, 2020

Incidence and prognostic factors of patients with synchronous liver metastases upon initial diagnosis of breast cancer: a population-based study.

Incidence and prognostic factors of patients with synchronous liver metastases upon initial diagnosis of breast cancer: a population-based study.

Journal: Cancer management and research
Published: December 13, 2018

Serum miR-4530 sensitizes breast cancer to neoadjuvant chemotherapy by suppressing RUNX2.

Serum miR-4530 sensitizes breast cancer to neoadjuvant chemotherapy by suppressing RUNX2.

Journal: Cancer management and research
Published: October 24, 2018

Effects of adjuvant chemotherapy in T1N0M0 triple-negative breast cancer.

Effects of adjuvant chemotherapy in T1N0M0 triple-negative breast cancer.

Journal: Breast (Edinburgh, Scotland)
Published: October 17, 2018

Nomogram for predicting preoperative lymph node involvement in patients with invasive micropapillary carcinoma of breast: a SEER population-based study.

Nomogram for predicting preoperative lymph node involvement in patients with invasive micropapillary carcinoma of breast: a SEER population-based study.

Journal: BMC cancer
Published: November 26, 2017

Genetic evaluation of BRCA1 associated a complex genes with triple-negative breast cancer susceptibility in Chinese women.

Genetic evaluation of BRCA1 associated a complex genes with triple-negative breast cancer susceptibility in Chinese women.

Journal: Oncotarget
Published: August 31, 2015

Differences in breast cancer characteristics and outcomes between Caucasian and Chinese women in the US.

Differences in breast cancer characteristics and outcomes between Caucasian and Chinese women in the US.

Journal: Oncotarget
Published: February 06, 2015

A Prospective Evaluation of the Association between a Single Nucleotide Polymorphism rs3775291 in Toll-Like Receptor 3 and Breast Cancer Relapse.

A Prospective Evaluation of the Association between a Single Nucleotide Polymorphism rs3775291 in Toll-Like Receptor 3 and Breast Cancer Relapse.

Journal: PloS one
Published: September 17, 2014

Cytidine Deaminase Axis Modulated by miR-484 Differentially Regulates Cell Proliferation and Chemoresistance in Breast Cancer.

Cytidine Deaminase Axis Modulated by miR-484 Differentially Regulates Cell Proliferation and Chemoresistance in Breast Cancer.

Journal: Cancer research
Published: August 08, 2014
Showing 1-12 of 12

Last Updated: 09/26/2026